Cel
The current test systems employed by Industry are poorly predictive for Drug induced liver injury (DILI). The ‘MIP-DILI’ project will address this situation by the development of innovative preclinical test systems which are both mechanism-based and of physiological, pharmacological and pathological relevance to DILI in humans. An iterative, tiered approach with respect to test compounds, test systems, bioanalysis and systems analysis will be adopted to evaluate existing models and develop new models that can provide validated test systems with respect to the prediction of specific forms of DILI and further elucidation of mechanisms. The approach will encompass completely characterised cell lines, well-defined and physiologically stable hepatocytes, multi-cell type in vitro models including novel bioreactors, animal models and appropriate ex vivo human cell models. A systematic analysis of data and iteration at each stage will select the ‘best’ cell line, animal model or pathway for further investigation moving from simple systems to more complex models with reference to relevant clinical and preclinical data on the various forms of DILI. Triangulation of human, in vitro and animal data will provide a fundamental understanding of how drugs can harm the liver. It will then be possible to define the application of each particular novel test system in the context of drug development, and its use in the prediction of liabilities associated with the various forms of DILI that occur in man. Just as importantly, the project will define those models that are not appropriate as decision-making tools for the prediction of DILI in man.
The MIP-DILI consortium contains Key Opinion Leaders from academia, the biotechnology sector and the pharmaceutical industry in the fields of drug development, drug metabolism, drug toxicology, drug hypersensitivity, liver immunology, liver cell biology, pharmacogenetics, systems biology and clinical adverse drug reactions.
Dziedzina nauki
Zaproszenie do składania wniosków
IMI-JU-03-2010
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Koordynator
151 85 Sodertaelje
Szwecja
Zobacz na mapie
Uczestnicy (27)
L69 7ZX Liverpool
Zobacz na mapie
1081 HV Amsterdam
Zobacz na mapie
17177 Stockholm
Zobacz na mapie
Zakończenie uczestnictwa
53127 Bonn
Zobacz na mapie
6726 SZEGED
Zobacz na mapie
35065 RENNES CEDEX
Zobacz na mapie
1000 Bruxelles
Zobacz na mapie
2311 EZ Leiden
Zobacz na mapie
413 46 Göteborg
Zobacz na mapie
67115 Plobsheim
Zobacz na mapie
69120 Heidelberg
Zobacz na mapie
79098 Freiburg
Zobacz na mapie
Zakończenie uczestnictwa
DD1 5JJ Dundee
Zobacz na mapie
65205 Wiesbaden
Zobacz na mapie
10154 New York
Zobacz na mapie
TW89GS Brentford
Zobacz na mapie
92284 Courbevoie
Zobacz na mapie
2340 Beerse
Zobacz na mapie
2500 Valby
Zobacz na mapie
64293 Darmstadt
Zobacz na mapie
02200 Espoo
Zobacz na mapie
94250 GENTILLY
Zobacz na mapie
1070 Bruxelles / Brussel
Zobacz na mapie
3584 CS Utrecht
Zobacz na mapie
LS11 5PS Leeds
Zobacz na mapie
81675 Muenchen
Zobacz na mapie
RG21 4FA Basingstoke
Zobacz na mapie